Device Trial Radar · NCT07912229
Early Feasibility Study of NeoChord Transcatheter Mitral Repair System
Last checked: Nov 19, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
15
Planned (sponsor's estimate)
Start
Feb 20, 2027
Primary completion
Feb 20, 2029
Study completion Feb 20, 2032
Sponsor
- Lead sponsor
- NeoChordNot on our public-company list
- Sponsor type
- Industry
- First posted
- Nov 3, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Safety and performance evaluation of Transcatheter Mitral Repair System in subjects with moderate to severe (\>3+) degenerative mitral regurgitation.
Conditions
- Degenerative Mitral Regurgitation
- Degenerative Mitral Regurgitation (MR) Due to Leaflet Prolapse
Interventions
Transcatheter Chordal RepairDevice
Transcatheter Mitral Valve Repair for Degenerative Mitral Regurgitation Due to Chordal Elongation or Rupture Resulting in Mitral Valve Prolapse
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary EndpointTime frame: 30 Days
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.